HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!


Improving genetic tests


Leo Wan

CSO & Co-Founder

Cathy Tie

CEO & Co-Founder

Company details

Ranomics is building the world’s first comprehensive knowledge base of functionally-characterized genetic variants to help determine their role in disease development and treatment. Even in the absence of established clinical evidence, knowing the impact that a genetic variant has on its protein’s biological function can provide strong evidence to support classification. By determining the functional impact of every missense variant in known disease-causing genes, we’re equipping clinical laboratories and healthcare organizations with the information they need to accurately assess the pathogenicity of novel and rare variants

Get In Touch with Ranomics

Please tell us a little bit about yourself and why you'd like to get connected. Ranomics + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.